Faron says first patient dosed in phase two Bexmab trial for cancer

Faron Pharmaceuticals Ltd on Tuesday announced that the first patient has been dosed in phase 2 of its Bexmab trial.

Faron is a Turku, Finland-based clinical-stage biopharmaceutical company...

Related Keywords

Finland ,Birge Berns ,Faron Pharmaceuticals Ltd On ,Alliance News ,Alliance News Ltd ,Pharmaceuticals Ltd ,Chief Medical Officer Birge ,Sabrina Penty ,All Rights ,Markets ,